Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation

Blood Cells, Molecules, and Diseases

Volumn 33, Issue 3, 2004, Pages 216-221

  Ruggeri, Loredana ^a   Capanni, Marusca ^a   Mancusi, Antonella ^a   Urbani, Elena ^a   Perruccio, Katia ^a   Burchielli, Emanuela ^a   Tosti, Antonella ^a   Topini, Fabiana ^a   Aversa, Franco ^a   Martelli, Massimo F ^a   Velardi, Andrea ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Haploidentical transplants; KIR; Natural killer cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOIMMUNITY; CANCER RECURRENCE; CELL ACTIVITY; CELL CLONING; CONFERENCE PAPER; DONOR; GENOTYPE; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA TYPING; HUMAN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; RISK; RISK FACTOR; T LYMPHOCYTE;

ANIMALS; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HOST VS GRAFT REACTION; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOCYTIC, ACUTE; TRANSPLANTATION, HOMOLOGOUS;

EID: 7444220619     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.08.005     Document Type: Conference Paper

References (24)

1. C. Anasetti, and A. Velardi Haematopoietic cell transplantation from HLA partially matched related donors K.G. Blume S.J. Forman F.R. Appelbaum Haematopoietic Cell Transplantation third ed. 2004 Blackwell Science
2. Y. Reisner, and M.F. Martelli Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol. Today 16 1995 437 440
3. E. Bachar-Lusting, N. Rachamim, and H.W. Li Megadose of T-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat. Med. 1 1995 1268 1273
4. F. Aversa, A. Tabilio, and A. Terenzi Successful engraftment of T-depleted haploidentical "three-loci" incompatible transplants in leukaemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
5. F. Aversa, A. Tabilio, and A. Velardi Treatment of high risk acute leukaemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype N. Engl. J. Med. 339 1998 1186 1193
6. K. Kärre, H.G. Ljunggren, and G. Piontek Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy Nature 319 1986 675 678
7. E. Ciccone, O. Viale, and D. Pende Specific lysis of allogeneic cells after activation of CD3-lymphocytes in mixed lymphocyte culture J. Exp. Med. 168 1988 2403 2408
8. E. Ciccone, M. Colonna, and O. Viale Susceptibility or resistance to lysis by alloreactive NK cells is governed by a gene in the human major histocompatibility complex between Bf and HLA-B Proc. Natl. Acad. Sci. U. S. A. 87 1990 9794 9797
9. M. Colonna, T. Spies, and J.L. Strominger Alloantigen recognition by two human Natural Killer cells is associated with HLA-C or a closely linked gene Proc. Natl. Acad. Sci. U. S. A. 89 1992 7983 7985
10. E. Ciccone, D. Pende, and O. Viale Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans J. Exp. Med. 175 1992 709 718
11. E. Ciccone, D. Pende, and O. Viale Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) J. Exp. Med. 176 1992 963 971
12. M. Colonna, E.G. Brooks, and M. Falco Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C Science 260 1993 1121 1124
13. M. Colonna, G. Borsellino, and Falco HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells Proc. Natl. Acad. Sci. U. S. A. 90 1993 1200 1204
14. E. Ciccone, D. Pende, and M. Vitale Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells Eur. J. Immunol. 24 1994 1003 1006
15. A. Velardi, and A. Moretta Role of natural killer cell alloreactivity in haematopoietic stem cell transplantation K. Atkinson W. Fibbe R. Champlin L. Ljungman J. Ritz M. Brenner Clinical Bone Marrow and Blood Stem Cell Transplantation third ed. 2004 Cambridge University
16. M. Uhrberg, N.M. Valiante, and B.P. Shum Human diversity in killer cell inhibitory receptor genes Immunity 7 1997 753 760
17. A. Velardi, L. Ruggeri, and M. Capanni Impact of NK cell alloreactivity on mismatched haematopoietic transplantation: an update on donor selection criteria and on transplantation outcomes Blood 102 2003 153a
18. L. Ruggeri, M. Capanni, and M. Casucci Role of natural killer cell alloreactivity in HLA-mismatched haematopoietic stem cell transplantation Blood 94 1999 333 339
19. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched haematopoietic transplants Science 295 2002 2097 2100
20. M.J. Pando, C.M. Gardiner, M. Gleimer, K.L. McQueen, and P. Parham The protein made from a common allele of KIR3DL1 (3DL*004) is poorly expressed at cell surfaces due to substitution at position 86 in Ig domain 0 and 182 in Ig domain 1 J. Immunol. 171 2003 6640 6647
21. S.S. Farag, T.A. Fehniger, and L. Ruggeri Natural killer cell receptors: new biology and insights into the graft versus leukaemia effect Blood 100 2002 1935 1947
22. A. Velardi, L. Ruggeri, A. Moretta, and L. Moretta NK-cells: a lesson from mismatched haematopoietic transplantation Trends Immunol. 23 2002 438 444
23. W.D. Shlomchik, M.S. Couzens, and C.B. Tang Prevention of graft versus host disease by inactivation of host antigen-presenting cells Science 285 1999 412 415
24. C.L. Mackall, F.T. Hakim, and A. Velardi The lympho-hematopoietic system: effector and target of graft-versus-host disease Ferrara Cooke Deeg Graft vs. Host Disease third ed. 2004 Marcel Dekker, Inc.